Quick Takeaways
- This page summarizes Christopher Bunka's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
- 1 reported transaction and 5 derivative rows are listed below.
- Filing timestamp: 29 Aug 2022, 17:18.
Quoteable Key Fact
"Christopher Bunka filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 29 Aug 2022."
Ownership activity is grounded in SEC Form 4 disclosures.
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | LEXX | common shares | 215,912 | 29 Aug 2022 | Private Holding Company | ||||||
| holding | LEXX | common shares | 273,543 | 29 Aug 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LEXX | Stock Options | Award | $0 | +30,000 | +42% | $0.000000 | 101,001 | 29 Aug 2022 | Common Shares | 30,000 | $2.91 | Direct | |
| holding | LEXX | Warrants | 6,667 | 29 Aug 2022 | Common Shares | 6,667 | $10.50 | Private Holding Company | ||||||
| holding | LEXX | Stock Options | 32,667 | 29 Aug 2022 | Common Shares | 26,000 | $5.83 | Direct | ||||||
| holding | LEXX | Stock Options | 56,001 | 29 Aug 2022 | Common Shares | 23,334 | $7.08 | Direct | ||||||
| holding | LEXX | Stock Options | 71,001 | 29 Aug 2022 | Common Shares | 15,000 | $6.23 | Direct |